Institute of Biomedical Research of Barcelona
News
The network approved by the Ministry of Science, Innovation and Universities, will be coordinated by Professor Jose Carlos Fernández-Checa and has the participation of four research groups linked t
Recent evidence indicates that decreased clearance of amyloid beta (Aβ) is the driving force leading to its toxic accumulation in late-onset (sporadic) Alzheimer’s disease. Levels and activity of
The work, published in Atherosclerosis, shows that the levels of the sLRP1 protein in blood can indicate the risk of cardiovascular disease in people who do not present any symptoms.
